Money and clinical treatment decisions: how information on costs affects Finnish medical doctors’ decision-making

 |  Login

Show simple item record

dc.contributor Aalto University en
dc.contributor Aalto-yliopisto fi
dc.contributor.advisor Torkki, Paulus
dc.contributor.advisor Kämäräinen, Vesa
dc.contributor.advisor Räsänen, Keijo Vuorela, Piia 2017-08-17T13:23:35Z 2017-08-17T13:23:35Z 2017
dc.description.abstract Healthcare expenditure is on the rise, forming currently 9,5 % of the gross national product in Finland. Further rising is anticipated with the ageing population. Medical doctors make treatment decisions, and therefore also make an impact on costs. A big health, social services and regional government reform is to be initiated in Finland. This will put pressure also on medical doctors to pay notice to healthcare costs. The purpose of this study was to find out how information on costs of treatment would affect Finnish medical doctors’ clinical decision-making. 56 doctors from three public healthcare organizations participated in an internet-based study spring 2017. They were given a hypothetical patient case along with evidence-based treatment options based on Current Care guidelines, and information on costs. Then, they were asked to evaluate whether cost information affected their clinical decision-making. They were also presented various claims on the relationship between costs and clinical effects, and asked about which stakeholders should evaluate this relationship. Two out of three medical doctors said that cost information does not affect clinical decisions making. In clinical decision-making, emphasis is on the clinical side. Many would, however, choose the most cost-effective treatment option, if the options were clinically equal. In case cost difference was remarkable, some might choose the cheaper but clinically less efficient option. As for stakeholders to evaluate the relationship between costs and treatment options, the respondents most often chose the medical doctor treating patient, local organizational managers, Ministry of Social Affairs and Health / Parliament, the National Advisory Board on Social Welfare and Health Care Ethics (ETENE). I hope this thesis will offer inspiration for healthcare managers when pondering, how medical doctors might be lead towards more cost-reducing practices. In this thesis, also costing systems applicable in healthcare were reviewed. Knowledge about these will be emphasized during the planned big health and social services reform in Finland. It is good also for the medical profession, which has a profound knowledge of the branch, to know how costs are formed. I further hope this thesis would serve to stimulate discussion on costs in healthcare among medical doctors and, also, on our possibility to affect these costs. en
dc.format.extent 91
dc.format.mimetype application/pdf en
dc.language.iso en en
dc.title Money and clinical treatment decisions: how information on costs affects Finnish medical doctors’ decision-making en
dc.type G2 Pro gradu, diplomityö fi Kauppakorkeakoulu fi School of Business en
dc.contributor.department Johtamisen laitos fi
dc.subject.keyword terveydenhuolto en
dc.subject.keyword kustannus en
dc.subject.keyword lääkäri en
dc.subject.keyword päätöksenteko en
dc.identifier.urn URN:NBN:fi:aalto-201708176685
dc.type.ontasot Master's thesis en
dc.type.ontasot Maisterin opinnäyte fi
dc.programme Management and International Business (MIB) en
dc.subject.helecon johtaminen fi
dc.subject.helecon kansainväliset yhtiöt fi
dc.subject.helecon terveydenhuolto fi
dc.subject.helecon kustannukset fi
dc.subject.helecon tieto fi
dc.subject.helecon päätöksenteko fi
dc.subject.helecon asiantuntijat fi
dc.subject.helecon terveystalous fi
dc.ethesisid 16013
dc.location P1 I fi

Files in this item

This item appears in the following Collection(s)

Show simple item record

Search archive

Advanced Search

article-iconSubmit a publication


My Account